Press Release ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population ClearNote Health December 18, 2024
Press Release Avantect Pancreatic Cancer Test Cost-Effective When Used as a Surveillance Tool in High-Risk Patients Newly Diagnosed with Diabetes ClearNote Health October 31, 2024
Press Release Avantect Ovarian Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services ClearNote Health September 26, 2024
Event American Diabetes Association 84th Scientific Sessions | June 21st – 24th, 2024 cnhnewcorpdev June 2, 2024
Event American Society of Clinical Oncology (ASCO) | May 31st – June 4th, 2024 cnhnewcorpdev June 1, 2024
